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Is aggregated synthetic amorphous silica
toxicologically relevant?
Sivakumar Murugadoss1, Sybille van den Brule2, Frederic Brassinne3, Noham Sebaihi4, Jorge Mejia5,
Stéphane Lucas6, Jasmine Petry4, Lode Godderis7,8, Jan Mast3, Dominique Lison2 and Peter H. Hoet1*
Abstract
Background: The regulatory definition(s) of nanomaterials (NMs) frequently uses the term ‘agglomerates and
aggregates’ (AA) despite the paucity of evidence that AA are significantly relevant from a nanotoxicological
perspective. This knowledge gap greatly affects the safety assessment and regulation of NMs, such as synthetic
amorphous silica (SAS). SAS is used in a large panel of industrial applications. They are primarily produced as nano-
sized particles (1–100 nm in diameter) and considered safe as they form large aggregates (> 100 nm) during the
production process. So far, it is indeed believed that large aggregates represent a weaker hazard compared to their
nano counterpart. Thus, we assessed the impact of SAS aggregation on in vitro cytotoxicity/biological activity to
address the toxicological relevance of aggregates of different sizes.
Results: We used a precipitated SAS dispersed by different methods, generating 4 ad-hoc suspensions with
different aggregate size distributions. Their effect on cell metabolic activity, cell viability, epithelial barrier integrity,
total glutathione content and, IL-8 and IL-6 secretion were investigated after 24 h exposure in human bronchial
epithelial (HBE), colon epithelial (Caco2) and monocytic cells (THP-1). We observed that the de-aggregated
suspension (DE-AGGR), predominantly composed of nano-sized aggregates, induced stronger effects in all the cell
lines than the aggregated suspension (AGGR). We then compared DE-AGGR with 2 suspensions fractionated from
AGGR: the precipitated fraction (PREC) and the supernatant fraction (SuperN). Very large aggregates in PREC were
found to be the least cytotoxic/biologically active compared to other suspensions. SuperN, which contains
aggregates larger in size (> 100 nm) than in DE-AGGR but smaller than PREC, exhibited similar activity as DE-AGGR.
Conclusion: Overall, aggregation resulted in reduced toxicological activity of SAS. However, when comparing
aggregates of different sizes, it appeared that aggregates > 100 nm were not necessarily less cytotoxic than their
nano-sized counterparts. This study suggests that aggregates of SAS are toxicologically relevant for the definition
of NMs.
Keywords: Nanomaterials, Synthetic amorphous silica, Aggregates, In vitro toxicity, Biological activity
Background
Synthetic amorphous silica (SAS) represents a group of
nanomaterials (NMs) manufactured either by thermal
(pyrogenic/fumed) or wet route (precipitated, gel and
colloidal) [1]. SAS is primarily produced as nano-sized
primary particles (1–100 nm in diameter) that form
micron-sized aggregates and agglomerates of aggregates
during their production process [2, 3]. Aggregates are
composed of particles that are strongly linked by
chemical bonding, whereas, in agglomerates, the parti-
cles/aggregates are bound together by reversible weak
forces such as charge and Van der Waals interactions
[4]. Thus aggregates are the smallest secondary structure
of SAS in their manufactured form.
SAS is widely used in industrial applications ranging
from food (food additive E551) and cosmetics to
pharmaceutical applications [1, 5–8]. SAS is traditionally
considered as non-toxic due to their amorphous nature
and several authors argued that it is very unlikely they
pose health hazards as they are aggregated in structures
of larger sizes [3, 9, 10]. However, our recent reviews in-
dicate that all types of SAS cause acute effects such as
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cytotoxicity in several cell types mainly via the induction
of oxidative stress and/or pro-inflammatory responses
[1, 11]. Some forms of SAS, such as colloidal SAS, have
also the potential to induce DNA damage in cell cul-
tures. However, while these studies focus on the hazard
of nano-sized SAS, influence of SAS aggregation on
cytotoxicity/biological acitivity remains unexplored.
In the recommended regulatory definition of NMs by
the European Union (EU), an important aspect is the
use of the term “aggregates”. It states that “manufac-
tured material containing particles, in an unbound state
or as an aggregate or as an agglomerate and where, for
50 % or more of the particles in the number size distribu-
tion, one or more external dimensions is in the size range
1 nm-100 nm” [12]. There is paucity of evidence that
AA are significantly relevant from a nanotoxicological
perspective.
Here we aim to determine the impact of SAS aggrega-
tion on their cytotoxicity/biological activities, and to
determine the toxicological relevance of aggregates of
different sizes using in vitro cell cultures. The most
quoted nanotoxicity paradigm is “the smaller the size of
the nanoparticles the greater the toxicity/biological re-
sponses” [13–16]. Therefore, we hypothesized that, small
aggregates of SAS induce stronger cytotoxicity compared
to their larger counterparts. We used a precipitated
amorphous silica (primary particle size 14–23 nm),
which is a representative of SAS used as food additives
[3]. Using different dispersion methods, we generated
four suspensions with different aggregate size distribu-
tions and tested their cytotoxicity/biological activities in
several cell types. Dispersions included de-aggregated
(by sonication) and aggregated (vortexed) SAS, as well as
fractionation of the aggregated suspension to separate
rapidly precipitating aggregates from others that remain
in suspension in the dispersion medium.
Results
Dispersion of SAS
Figure 1 shows how the four different suspensions of
SAS were freshly prepared before each independent ex-
periment. The ‘DE-AGGR’ suspension was prepared
using the generic NANOGENOTOX protocol [17] deliv-
ering the energy of 7056 J to the suspension by sonic-
ation. The ‘AGGR’ suspension was prepared in the same
dispersion medium and vortexed for 10 s. The super-
natant ‘SuperN’ and precipitate ‘PREC’ suspensions were
obtained from the ‘AGGR’ suspension by leaving it un-
disturbed for 15 min (see materials and methods).
Size characterization of SAS suspensions
Transmission electron microscopy (TEM) micrographs
revealed that SAS in the DE-AGGR fraction (Fig. 2a)
were much less aggregated than in AGGR (Fig. 2b),
SuperN (Fig. 2c) and PREC (Fig. 2d). Aggregates in all
suspensions showed a fractal-like structure. Table 1
shows the size of SAS in the different suspensions mea-
sured by TEM and dynamic light scattering (DLS). The
mean equivalent circle diameter (ECD) was 100 nm for
DE-AGGR and 2000 nm for AGGR. The mean hydro-
dynamic diameter (Z-average) of DE-AGGR was 264 nm
and 10 μm for AGGR. Feret min, which describes the
smallest external dimension according to the EU defin-
ition, was 28 nm and 600 nm for DE-AGGR and AGGR
SAS, respectively. Feret min and ECD analysis was not
possible for PREC and SuperN due to their low stock
concentration, therefore, the sizes were manually mea-
sured (arbitrary line measurement) and determined as
Fig. 1 Preparation of synthetic amorphous silica suspensions (SAS). DE-AGGR - 2.56 mg/mL of SAS sonicated with an energy of 7056 J (a); AGGR -
2.56 mg/mL of SAS vortexed for 10 s (b); SuperN (0.64 mg/mL) - AGGR dispersion left undisturbed for 15 min after vortexing and fractionated in
supernatant (c) and PREC (1.92 mg/mL) - precipitates of AGGR (d)
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600 and 750 nm, respectively; Z-average of SuperN and
PREC suspension was around 3953 nm and 3332 nm.
Measurements by centrifugal liquid sedimentation
(CLS), given its larger useful range, is somewhat less
dependent on the stability of the samples. Therefore,
CLS was used to measure the approximate sizes of
SuperN and PREC aggregates and the results revealed
some slight differences between SuperN and PREC.
SuperN was mainly composed of one size population
(mean size 4580 nm) and PREC of two populations
(3900 nm and 6370 nm) (data not shown in the table). In
conclusion, a clear difference in size distribution was ob-
served for DE-AGGR and AGGR. Although SuperN and
PREC appeared visually different (Fig. 1), such difference
could not be established using TEM, DLS or CLS.
To establish the difference between PREC and
SuperN, images were taken using bright field micros-
copy (Fig. 3). Pictures indicate that the aggregates in
PREC (Fig. 3d) are much larger than the aggregates in
SuperN (Fig. 3c) and DE-AGGR (Fig. 3a). Using an ar-
bitrary line measurement tool, the size of 100 aggre-
gates from representative pictures were measured
manually. The mean size of PREC aggregates was
roughly about 25 μm in diameter while SuperN aggre-
gates measured only 2.5 μm. In conclusion, we showed
by different approaches that all suspensions generated
in this study were composed of aggregates of different
size distributions.
The stability of the suspensions in exposure media was
measured by DLS (Table 2). The stock suspensions were
Fig. 2 Representative TEM micrographs of freshly prepared SAS stock suspensions. DE-AGGR (a), AGGR (b), SuperN (c) and PREC (d)
Table 1 Size characterization of SAS dispersed in 0.05% Bovine Serum Albumin (BSA)
Stock
suspensions
Stock
concentration
(mg/mL)
TEM DLS
Mean ECD (nm) Mean Feret min (nm) Z-average (nm)
DE-AGGR 2.56 100 ± 14 28 ± 0.6 264
AGGR 2.56 2000 600 12,530
SuperN 0.64 600a n/a 3953
PREC 1.92 750a n/a 3332
Mean equivalent circle diameter (ECD) and mean feret minimum (Feret min) measured by TEM; Mean hydrodynamic diameter (Z-average) by DLS; n/a-not
available. asize was measured manually using the arbitrary line measurement tool of the iTEM software
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diluted in different exposure media and mean sizes were
measured directly and after 24 h. Z-average of DE-
AGGR SAS in DMEM/F12 (used for HBE cell cultures)
and RPMI 1640 (used for THP-1) exposure media was
approximately 225 nm and remained unchanged after
24 h except in DMEM/HG medium (used for Caco2), in
which Z-average increased to 1275 nm. The mean size of
SuperN was 4 μm at the beginning, and did not drastic-
ally change after 24 h (except in DMEM/HG). Although
the measurements of AGGR and PREC do not reflect
the size of aggregates, the results are given in the table
for completeness.
Si quantification in SAS SuperN and PREC suspensions
The quantification of Si by inductively coupled plasma
mass spectrometry (ICP-MS) in SuperN and PREC sus-
pensions derived from the AGGR suspension indicated
that Si was distributed in each fraction at a ratio of
24.7% ± 0.67 (mean ± SEM) in SuperN and 75.3% ± 0.67
for PREC. Therefore, the mass concentration of PREC
Fig. 3 Representative bright field microscopic images of freshly prepared SAS stock suspensions. DE-AGGR (a), AGGR (b), SuperN (c) and PREC (d).
Scale bar -20 μm
Table 2 Size characterization of SAS in stock suspensions and exposure media (for HBE, Caco2 and THP-1) using DLS
Stock HBE Caco2 THP1
AM Z-avg PDI Z-avg PDI Z-avg PDI Z-avg PDI
DE-AGGR 0 h 264 0.33 228 0.35 225 0.34 228 0.36
24 h 260 0.32 233 0.37 1275 0.28 226 0.42
AGGR 0 h 10,040 0.90 3212 0.72 4321 0.82 3566 0.97
24 h 12,374 0.88 3059 0.80 1637 0.46 2688 0.75
SuperN 0 h 3953 0.94 4507 0.87 4500 0.89 4507 0.95
24 h 3661 1.00 3851 0.83 2233 0.85 3866 0.95
PREC 0 h 3332 0.90 1101 0.85 1370 0.83 1561 0.93
24 h 4329 0.96 957 0.88 1376 0.82 955 0.91
Freshly prepared stock suspensions were diluted to 100 μg/mL in different exposure media (without serum) and, hydrodynamic sizes (Z-avg) and polydispersity
index (PDI) were measured directly and after 24 h (incubated at 37 °C)
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and SuperN suspensions were determined as 1.92 mg/
mL and 0.64 mg/mL, respectively.
Influence of aggregation on in vitro dosimetry
In vitro dosimetry simulation was performed using
DMEM/F12 (used for HBE cell cultures) and RPMI 1640
(THP-1) because SAS diluted in DMEM/HG (Caco2) ex-
posure medium agglomerated further over 24 h incuba-
tion (change in agglomerate size > 30%) and did not
meet the criteria to apply the volume centrifugation
method (VCM) method. Additional file 1: Table S1 lists
the main parameters used to perform the dosimetry
simulation and Fig. 4 shows the estimated SAS concen-
tration reaching the bottom of the wells as a function of
nominal (applied) dose. Regardless of the exposure
media, nearly 7–9% of the DE-AGGR applied concentra-
tion reached the cells while it was at least 5-fold higher
for AGGR SAS (41–47%) at the simulated concentra-
tions (Fig. 4a and c). It is important to mention here that
the delivered concentrations for AGGR could be under-
estimated since the DLS size used for dosimetry simula-
tion did not reflect the PREC aggregates in AGGR
suspension. Based on ICP-MS analysis, we found that
the highest concentration tested for SuperN suspension
in biological experiments was 32 μg/mL. Therefore, the
dosimetry for SuperN was simulated for nominal con-
centrations from 2 to 32 μg/mL and compared with DE-
AGGR (Fig. 4b and d). The delivered dose between these
suspensions was not substantially different. The percent-
age of concentrations delivered to the cells also did not
differ much for 96 and 24 well plates as the height of the
cell culture medium was similar (6 mm).
Comparison of in vitro biological responses
Food additive SAS are produced in large quantity.
Therefore, in addition to ingestion, exposure via inhal-
ation during production and processing is also inevit-
able. Therefore, we used both a human bronchial
(16HBE14o- or HBE) and colon epithelial cell line
(Caco2) to investigate the cytotoxic effects in vitro. In
addition, we used a human monocytic cell line (THP-1)
as monocytes/macrophages are the first line of defence
once particles enter into the body. Physiologically
relevant doses for short term exposure (0–128 μg/mL)
estimated from Occupational Exposure Limits (OELs) of
amorphous silica were used in this study [11]. To inves-
tigate the short-term cytotoxicity/biological activity
in vitro, we assessed different endpoints including
Fig. 4 Estimated concentration reaching the bottom of the wells after 24 h as a function of nominal concentrations applied in cell based assays.
Dosimetry simulation was performed by a distorted grid (DG) model and compared for different SAS suspensions using parameters obtained
from exposure media DMEM/F12 (a and b) and RPMI 1640 (c and d). The slope values are indicated near the respective lines. R2 > 0.9 for all the
suspensions. The percentage of dose delivered to the cells did not differ in 96 or 24 well plates, as the height of the liquid column was
equal (6 mm)
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cytotoxicity, oxidative stress, epithelial barrier integrity
and pro-inflammatory responses.
Since this study aims to compare the magnitude of re-
sponses induced by aggregates of different sizes, we first
selected endpoints for which a significant response was
recorded (Table 3). If no impact of SAS treatment on a
given endpoint was measured, this endpoint was not fur-
ther investigated. In a second step, we analysed only the
endpoints showing a significant difference after exposure
to SAS. Detailed data for all the endpoints are presented
only in Additional file 1: Figure S1-S3.
To determine the impact of aggregation, we first com-
pared DE-AGGR and AGGR suspensions using two-way
ANOVA. If differences were observed, a post hoc test
(Bonferroni’s multiple comparison test) was used to
determine which suspension induced a stronger effect at
the same mass concentrations (Table 4a). When com-
paring DE-AGGR vs AGGR, there was a significant dif-
ference in 14 comparisons out of 16, with DE-AGGR
inducing more pronounced effects than AGGR (see
Table 4a and Additional file 1: Figure S1).
Secondly, we compared AGGR with SuperN and PREC
(see Table 4b and Additional file 1: Figure S2). It is im-
portant to mention here that the concentrations of
SuperN and PREC suspensions were not adjusted to the
AGGR concentrations in this analysis (please refer to the
in vitro exposure conditions for explanation), which
allows to determine which of the SuperN or PREC sus-
pension accounts more for the effects induced by
AGGR. When comparing AGGR vs SuperN, 9 out of 14
comparisons indicate that AGGR suspensions induced
similar effects as SuperN (no significant difference).
When comparing AGGR vs PREC, 9 out of 12 compari-
sons showed that AGGR induced significantly stronger
effects compared to PREC. These results suggest that
the SuperN fraction accounts more for the effects in-
duced by AGGR than PREC.
Finally, to determine the toxic potency of SuperN
aggregates in comparison to the nano-sized aggre-
gates, we compared SuperN (the dose was adjusted
based of ICP-MS measurements) with DE-AGGR at
mass concentrations between 2 and 32 μg/mL. The
summary of the results are presented in Table 4c and
Additional file 1: Figure S3. Intriguingly, most com-
parisons (11 out of 14) indicated that SuperN and
DE-AGGR induced similar effects except for the LDH
assay in HBE and Caco2, and GSH depletion in THP-1,
where DE-AGGR was more potent than SuperN.
Discussion
To determine the impact of NM aggregation, we com-
pared the in vitro cytotoxicity/biological activities in-
duced by de-aggregated SAS (DE-AGGR) produced by
sonication at 7056 J and aggregated SAS (AGGR) in a
vortexed suspension. The AGGR SAS was also fraction-
ated into two suspensions based on aggregate sedimen-
tation (PREC and SuperN) and we also, compared their
cytotoxicity/biological activities separately and compared
to AGGR and DE-AGGR. Overall, aggregation resulted
in reduced toxicological activity of SAS. We observed
that large precipitating aggregates (PREC) were the least
cytotoxic/biologically active. Interestingly, aggregates in
SuperN, which were larger (> 100 nm) than DE-AGGR
aggregates (< 100 nm), exhibited similar activity as DE-
AGGR.
Preparation of the suspensions with aggregates of differ-
ent sizes were crucial in our study, but no standardized
protocol with minimal changes in dispersion medium has
been developed so far [1, 11]. Therefore, we explored the
potential of applying different levels of energy by sonic-
ation to obtain different aggregate sizes. This indeed re-
sulted in de-aggregation of SAS but did not yield sizes
with substantial differences whatever the energy delivered
(≥ 882 J, see Additional file 2: Figure S4). A recent study
also showed that different sonication energies used to dis-
perse SAS did not strongly affect the size distribution and
hence the biological effects [18]. Therefore, we used a
mechanically vortexed suspension (AGGR) to obtain a size
distribution different from DE-AGGR. European Food
Safety Authority (EFSA), in its recent scientific opinion,
insisted that the size distribution used so far in
toxicological studies (mostly de-aggregated NPs like the
Table 3 Summary of the in vitro responses to SAS exposure
Biological endpoints AGGR DE-AGGR SuperN PREC
HBE Caco2 THP1 HBE Caco2 THP1 HBE Caco2 THP1 HBE Caco2 THP1
Cell metabolic activity No Yes Yes Yes Yes Yes No Yes Yes No No Yes
Cell viability Yes No Yes Yes Yes Yes No Yes Yes No No No
GSH Yes Yes Yes Yes Yes Yes Yes Yes Yes No No No
TEER Yes No n/a Yes Yes n/a Yes Yes n/a No No n/a
IL-8 No Yes Yes Yes Yes Yes Yes Yes Yes Yes No No
IL-6 No No No Yes Yes No Yes No No Yes No No
“Yes” indicates p < 0.05 (One-way ANOVA) and there is a significant difference compared to control at any of the tested concentrations; “No” indicates when p > 0.05
and no difference compared to control; n/a - not available
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DE-AGGR suspension presented here), might not be fully
representative of SAS in their pristine form [19]. There-
fore, the AGGR suspension produced by vortexing in this
study might represent a better model of SAS in their
pristine (manufactured) form.
The size characterization of SAS suspensions was not
straightforward and technically challenging due to the
polydisperse size distribution. The PREC fraction of
AGGR, predominantly composed of large aggregates
(few tens micrometers), did not appear different from
SuperN fraction based on TEM, DLS or CLS. This can
due to the fact that the PREC aggregates are not dis-
persed properly for TEM or DLS measurements. For
TEM grid preparations, grid-on-drop method was used
(refer to [20] for method description) and possibly, this
method did not allow very large aggregates to attach to
the EM grid due to their quick sedimentation/precipita-
tion. For DLS, very large aggregates might also have
sedimented very rapidly and were missed in the ana-
lysis. Therefore, measurements for AGGR and PREC
might actually not reflect reality. The CLS technique,
which separate particles/aggregates by sizes using cen-
trifugal sedimentation, also did not detect these very
large aggregates at the lowest centrifugal speed possible
because of its limitation to detect particles/aggregates
> 20 μm. However, aggregates > 20 μm were easily de-
tected using bright field microscopy. In conclusion, it
appeared that a panel of techniques are required to
Table 4 Summary of in vitro responses to differently aggregated SAS suspensions
“Green” indicates p>0.05 (Two-way ANOVA) and no significant difference between the suspensions; “Red” indicates p<0.05 and a significant difference between
the suspensions - in this case, Bonferroni’s multiple comparison test was used to statistically determine which suspension induced the strongest effect; nc-not
compared as both suspensions did not induce any significant activity compared to control
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reveal the true size distribution of polydispersed NMs
containing large aggregates.
SAS in their pristine form, exist as aggregates of few
hundred nanometers to few hundred micrometers [2, 3].
Size characterization of AGGR suspension indicated that
the particles were not only strongly aggregated but also
showed a high polydispersity in size. On the other hand,
DE-AGGR SAS were prepared by sonication, which is
the standard technique to prepare well-dispersed (least
aggregated or agglomerated) suspensions and to
characterize the hazard of nanoparticles. Size distribu-
tion analysis of DE-AGGR showed that particles in this
suspension were in their least aggregated form compared
to other suspensions, which is consistent with the results
obtained using the same dispersion protocol [21]. In
addition, though dosimetry simulation indicated that
much higher dose was delivered to cells for AGGR com-
pared to DE-AGGR SAS, AGGR SAS were consistently
less active in cell based assays than DE-AGGR. Further-
more, although changes in SAS behaviour (further ag-
glomeration) was noticed when different biological
exposure media were used, the activity was not much in-
fluenced by the cell types. This indicates that the
changes in particle characteristics in exposure media
and delivered doses were not essential confounders for
differential responses observed with these suspensions.
While preparing AGGR suspensions, we noticed two
fractions, one that quickly sedimented in a few min
(PREC) and the other that remained in suspension
(SuperN) for hours. Hence we studied their activity sep-
arately. Large aggregates in the PREC suspension did not
show any or a weak biological activity although its mass
concentration was 75% of the AGGR suspension
(Table 3). Rapidly sedimenting agglomerates were re-
ported to be more cytotoxic than the one that sediment
slowly [22, 23]. However, in the present study, rapid
sedimentation and hence high local concentration of
large aggregates, did not result in cellular damage, pos-
sibly because these aggregates were too large for cellular
interaction and uptake, and/or might not demonstrate
any nanoscale associated properties.
SuperN aggregates, which were larger than DE-AGGR,
showed similar cytotoxic/biological activity as DE-
AGGR. Most importantly, delivered doses was not a
confounder when comparing AGGR and SuperN aggre-
gates. These findings are somewhat in contrast with
studies demonstrating that sub-micron and micron sized
silica particles were less potent compared to nano-sized
silica [13, 24, 25], suggesting that the size alone may not
be necessarily the key determinant of toxicity of aggre-
gated SAS. Apart from size, other physico-chemical
characteristics of nanoparticles such as shape also influ-
ence the cellular interactions and toxicity. Particles with
sharper angular features or elongated were efficiently
taken up by cells compared to the spherical ones [26–
28]. In this study, SuperN aggregates were mostly non-
spherical and exhibited fractal-like structure. Further,
despite the fact that the size of these aggregates is far
greater than the nano-range, they may still possess the
surface of the primary particles. Thus, physico-chemical
characteristics such as shape, surface reactivity and sta-
bility in aqueous suspension, might contribute to the
toxic potential.
The physicochemical properties of different types of
silica NM might be different [1] and hence their bio-
logical activity [29]. Therefore, the results of this study
may only be applicable to the precipitated silica used
here, although this approach can be applied to investi-
gate the toxicity of other types of SAS or other NMs.
Conclusion
This study aimed to assess the impact of aggregation on
cytotoxic/biological activities in submerged cell cultures
and the toxicological relevance of SAS aggregates of dif-
ferent sizes. In general, aggregation resulted in reduced
toxicological activity of SAS. Looking closer, the large,
quickly precipitating aggregates (PREC) exhibited the
lowest cytotoxicity/biological activity in vitro. On the
other hand, an important fraction (25% of the mass of
AGGR) of non-precipitating aggregates (SuperN), which
contains aggregates larger than 100 nm, exhibited similar
activities as nano-sized aggregates (DE-AGGR). We con-
clude that aggregates with size greater than 100 nm
should not be necessarily considered as less toxic than
their nano-sized counterparts. This study suggests that
aggregates of SAS are toxicologically relevant and should
be part of the definition of NMs.
Materials and methods
SAS NMs
The European Commission’s Joint Research Centre (JRC,
Italy) kindly provided the representative NM silica
JRCNM02000. Detailed physico-chemical characterization
in their manufactured form is provided in the technical re-
port of JRC [21].
Dispersion of SAS
The ‘DE-AGGR’ suspension was prepared using the gen-
eric NANOGENOTOX protocol [17]: 15.36 mg SAS
were pre-wetted with 30 μL EtOH and then suspended
in 5.970 mL bovine serum albumin (BSA) 0.05% (2.56
mg SAS/mL, final volume 6mL). Then the suspension
was sonicated for 16 min (energy 7056 joules, Microson
XL 2000, 3 mm probe, Belgium).
The ‘AGGR’ suspension was prepared as follows:
15.36 mg SAS were pre-wetted with 30 μL EtOH and
then suspended in 5.970 mL BSA 0.05% (2.56 mg SAS/
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mL, final volume 6mL). This suspension was then vor-
texed for 10 s.
The ‘SuperN’ and ‘PREC’ suspensions were obtained
from the ‘AGGR’ suspension by leaving it undisturbed
for 15 min: the supernatant (5.8 mL) was removed and
200 μL of 0.05% BSA was added (‘SuperN’ fraction, final
volume 6mL); and 5.8 mL 0.05% BSA was added to the
precipitate (‘PREC’ fraction, final volume 6mL), which
was redispersed by vortexing for 10 s.
Dynamic light scattering (DLS)
DLS measurements were performed using a ZetaSizer Nano
ZS instrument (Malvern Instruments, Malvern, UK) to
evaluate the size distribution of SAS in suspensions. Freshly
prepared stock suspensions and SAS in cell exposure
medium (100 μg/mL) were tested for each condition. The
settings were 1.544 for the refractive index and 0.2 for the
absorption parameter. The selected dispersant was water
(refractive index, 1.33). The mean hydrodynamic diameter
(Z-average) and the polydispersity index (PDI) were mea-
sured using the version 7.11 of the Zetasizer software.
Transmission Electron microscopy (TEM)
TEM specimens of freshly prepared suspensions were
prepared by the “grid on top”method and examined
using a well-aligned Tecnai Spirit microscope (FEI, Eind-
hoven, Netherlands) operating at 120 kV, at a spot size 3
and imaged in BF-mode in parallel beam conditions. Im-
ages were typically recorded at approximately 500 nm
below minimal contrast conditions. Digital micrographs
were made using the bottom-mounted 4 × 4 K Eagle
CCD-camera and converted to tif-format using the TIA
software. Equivalent circle (ECD) and Feret minimum
diameter (Feret min diameter) measurements were per-
formed as described in [20] .
Centrifugal liquid sedimentation (CLS)
CLS measurements were performed with a DC24000
system (CPS instruments Inc., Stuart, Florida, USA),
equipped with a 405-nm wavelength laser detector, with
polystyrene particles standard (nominal particle size =
10 μm) at a centrifugal speed of 2000 rpm. Speed was
chosen in order to increase resolution of micron size ag-
gregates. Sizes are expressed in terms of hydrodynamic
diameter assuming all particles are spherical. Each meas-
urement was done by injecting 1 ml of a 0.64 mg SAS/
mL for SuperN or 1 ml of 10 mg/mL for PREC.
Bright field (BF) microscopy
A drop of freshly prepared suspensions was placed on a
slide and covered with a cover slip. The images were
taken immediately using microscopy (BX61, Olympus,
Belgium) in a BF mode and at a magnification of 40x.
The diameter of 100 particles from the pictures was
measured using an in-built arbitrary line measurement
tool and the mean diameter was calculated.
In vitro dosimetry
The Volume Centrifugation Method (VCM) was used to
determine the effective density of SAS in cell exposure
medium and the SAS concentration delivered to the
cells over 24 h exposure was simulated using the
Distorted Grid (DG) model as described in [30]. The re-
sults are presented as a function of nominal doses (pre-
sented as μg/mL).
Inductively coupled plasma-mass spectrometry (ICP-MS)
Si was quantified directly in SAS SuperN and PREC sus-
pensions by ICP-MS (Agilent 7500ce Octopole Reaction
System, Santa Clara, USA) using a collision cell in he-
lium mode, Sc as internal standard (Merck, Darmstadt,
Germany) and a six-point calibration curve (Si standard,
Merck). Measurements were carried out in 3 independ-
ent experiments on 28Si and 45Sc.
Cell culture conditions
The human bronchial epithelial cell line (16HBE14o- or
HBE) and the human monocytic cell line (THP-1) were
kindly provided by Dr. Gruenert (University of Califor-
nia, San Francisco, USA). HBE cells were cultured in
DMEM/F12 supplemented with 5% fetal bovine serum
(FBS), 1% penicillin-streptomycin (P-S) (100 U/mL), 1% L-
glutamine (2mM) and 1% fungizone (2.5 g/mL) while
RPMI 1640 supplemented with 10% FBS, 1% P-S (100 U/
mL), 1% L-glutamine (2mM) and 1% fungizone (2.5 g/mL)
was used for THP-1. Caucasian colon adenocarcinoma cell
line (Caco2) (P.Nr: 86010202) was purchased from Sigma-
Aldrich (Belgium). DMEM/HG supplemented with 10%
FBS, 1% P-S (100 U/mL), 1% L-glutamine (2mM), 1% fun-
gizone (2.5 g/mL) and 1% non-essential amino acids
(NEAA) was used for Caco2 cells. All cell culture supple-
ments were purchased from Invitrogen (Belgium) unless
otherwise stated. Cells were cultured in T75 flasks (FAL-
CON, USA) at 37 °C in a 100% humidified air containing
5% CO2. Fresh medium was changed every 2 or 3 days and
cells were passaged every week. Cells from passage 4 to 10
were used for the experiments.
In vitro exposure conditions
DE-AGGR and AGGR suspensions (2.56 mg/mL) were
freshly prepared and diluted in BSA 0.05% to prepare
different concentrations (20 μg/mL - 1280 μg/mL) and fur-
ther diluted 10 times in serum-free exposure medium to
achieve the final exposure concentrations (2–128 μg/mL).
Regardless of mass concentrations in SuperN and PREC
fractions, stocks were prepared and diluted exactly the
same way as for AGGR and DE-AGGR suspensions. For
toxicity testing, submerged cell cultures were used. For all
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THP-1 cells were seeded at a density of 1.5 × 105, 1.05 × 105
cm2 (surface area of culture well) and 3 × 105/mL respect-
ively in 96 or 24 well plates (Greiner bio-one, Belgium). For
the adherent cell-types (HBE and Caco2), the cell cultures
were exposed as confluent cultures, to resemble as closely
as possible NP exposure at the lung and intestinal epithelial
barriers (in vivo and/or in humans). For non-adherent
monocytic cell line (THP-1), the density 3 × 105 cells/mL
was selected based on the density of monocytes in 1mL of
human blood (3 × 105 - 10 × 105 monocytes/mL). After
seeding and overnight incubation at 37 °C, cells were
washed with HBSS (without Ca2+/Mg2+) once and exposed
to different concentrations of SAS for 24 h. Cell cultures ex-
posed to BSA 0.05% diluted ten times in serum-free expos-
ure medium served as untreated control. After 24 h
exposure, the cell cultures were washed twice with HBSS
and the respective assays were performed.
Cell metabolic activity
To determine cell metabolic activity, cell culture superna-
tants were removed after 24 h exposure and cells were in-
cubated with 120 μL water soluble tetrazolium salts
(WST-1) reagent (Roche, Belgium) diluted in medium
without phenol red at the ratio of 1:10. After 1 to 2 h incu-
bation at 37 °C, plates were centrifuged at 1600 g for 10
min, 100 μL was transferred to a new plate and the optical
density (OD) was recorded using a micro-plate reader
(Bio-Rad, USA) at 450 nm. After subtracting the blank
OD values from the sample OD values, results were
expressed as percentage of control (untreated) cells.
Effect on cell viability
Effect on cell viability was assessed by cellular leakage of
lactate dehydrogenase (LDH) using a kinetic assay [31].
At the end of exposure, supernatants were transferred to
a new plate and cells were incubated with triton 0.2%
(Sigma-Aldrich, Belgium). After 30 min, plates were cen-
trifuged at 1600 g for 10 min. After transfer to a new
plate, freshly prepared substrate solution (pyruvate +
NADH) was added and the absorbance was measured by
a spectrophotometer at 340 nm for 3 min with 15 s inter-
val. Slope was calculated according to the standard
curve. Cell viability was calculated as
slope of leakage= slope of lysate þ slope of leakageð Þ100½ 
and relative viability as

sample viability=
untreated control viability
100
Total glutathione measurements
Total glutathione (GSH) is a cellular antioxidant, which
is depleted when excessive reactive oxygen species
(ROS) are produced. Therefore, GSH depletion was
measured as an indicator of oxidative stress [32] using a
GSH detection kit (Enzo life sciences, Belgium). After
24 h exposure, cell cultures were washed and harvested
using trypsin 0.1% (Gibco, Belgium). Then, cells were re-
suspended in metaphosphoric acid 5% and homogenized
using an ultra turrax t25 tissue homogenizer (Janke &
kunkel, Germany). GSH was quantified according to
manufacturer’s protocol and the protein content of cell
cultures was assessed by the bicinchoninic acid (BCA)
protein assay kit (Thermo Scientific Pierce, Belgium).
GSH was normalized to the total protein content and
the results were expressed as percentage of control (un-
treated) cells.
Cytokine quantification
As indicators of pro-inflammatory responses, IL-8 and
IL-6 levels were measured using enzyme-linked im-
munosorbent assay (ELISA) kits (Sigma-Aldrich,
Belgium) in cell supernatants collected after 24 h expos-
ure according to manufacturer’s protocol. Results were
normalized to the total protein content and expressed as
a ratio to control (untreated) cells. Cells treated with li-
popolysaccharides 1 μg/mL were used as positive control
(data not shown).
Trans epithelial electrical resistance (TEER)
TEER was measured in epithelial (HBE and Caco2)
monolayers as an estimation of epithelial barrier integ-
rity. HBE and Caco2 cells were seeded at a density of
2.104 cells per well in 24 well transwell inserts (0.4 μm
pore size, polyester membrane, Corning, CLS3470
Sigma). TEER was monitored everyday using a Chop-
stick electrode and an epithelial voltohmmeter (EVOM)
(World Precision Instruments, Sarasota, USA). After 7 d,
cultures with TEER > 600Ω.cm2 were exposed to different
concentrations of SAS suspensions for 24 h and TEER was
measured. Cultures exposed to sodium dodecyl sulfate
(SDS) 200 μg/mL served as positive control for barrier in-
tegrity disruption (data not shown). Results were
expressed as percentage of control (untreated) cells.
Statistical analysis
Three independent experiments were performed in trip-
licate or duplicate and data were presented as mean ±
standard deviation (SD). Using GraphPad prism 7 soft-
ware (https://www.graphpad.com/), results were ana-
lysed with one-way ANOVA followed by a Dunnett’s
multiple comparison test to determine the significance
of differences compared to control. Two-way ANOVA
followed by Bonferroni’s multiple comparison test was
used to determine significance of differences between
suspensions (see Table 4 for explanation).
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cell culture medium height. The hydrodynamic sizes are given in Table 2.
Figure S1. Influence of SAS aggregation on cytotoxicity and biological
responses. Figure S2. Influence of SAS aggregation on cytotoxicity and
biological responses. Figure S3. Influence of SAS aggregation on
cytotoxicity and biological responses.
Additional file 2: Figure S4. Effect of probe sonication energy on the
size distribution of synthetic amorphous silica (SAS).
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